Abstract: Disclosed is a method of inducing non-alcoholic steato-hepatitis in a multi-component liver spheroid. The method includes harvesting or reviving a cryopreserved sample of two or more distinct primary liver cell types and seeding a mixture of at least two or more distinct primary liver cell types to generate a multi-component liver spheroid. Disclosed are mono-component and multi component liver spheroid. The method further includes inducing steatosis in the multi-component liver spheroid through treatment of one or more steatosis inducers, inducing steatohepatitis in the multi-component liver spheroid through a combinatorial treatment of a mixture of the one or more steatosis inducers and one or more fibrosis inducers; and inducing fibrosis in the multi-component liver spheroid through treatment with one or more fibrosis inducers.
| # | Name | Date |
|---|---|---|
| 1 | 202517015217-STATEMENT OF UNDERTAKING (FORM 3) [21-02-2025(online)].pdf | 2025-02-21 |
| 2 | 202517015217-REQUEST FOR EXAMINATION (FORM-18) [21-02-2025(online)].pdf | 2025-02-21 |
| 3 | 202517015217-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [21-02-2025(online)].pdf | 2025-02-21 |
| 4 | 202517015217-FORM 18 [21-02-2025(online)].pdf | 2025-02-21 |
| 5 | 202517015217-FORM 1 [21-02-2025(online)].pdf | 2025-02-21 |
| 6 | 202517015217-DRAWINGS [21-02-2025(online)].pdf | 2025-02-21 |
| 7 | 202517015217-DECLARATION OF INVENTORSHIP (FORM 5) [21-02-2025(online)].pdf | 2025-02-21 |
| 8 | 202517015217-COMPLETE SPECIFICATION [21-02-2025(online)].pdf | 2025-02-21 |
| 9 | 202517015217-FORM-26 [08-04-2025(online)].pdf | 2025-04-08 |
| 10 | 202517015217-FORM 3 [12-08-2025(online)].pdf | 2025-08-12 |
| 11 | 202517015217-Proof of Right [20-08-2025(online)].pdf | 2025-08-20 |